Bret Kenwell

Bret Kenwell

Expertise: Automotive Stocks, Growth Stocks, Tech Stocks, Dividends

Education: Studied finance at Central Michigan University

About Bret:
Bret Kenwell has been publicly writing about and analyzing the stock market for more than 10 years. What started off as fundamental analysis of strong businesses has morphed into a rigorous process that blends both fundamental and technical analysis.

While he still seeks out the strong businesses and dependable dividends he was attracted to early on, Bret has narrowed his focus to technology, automotive, and high-quality, high-growth businesses.

In that effort, he seeks Future Blue Chips — which is also the name of his website and newsletter.

Bret’s writing has sent him to unique places and events, like auto shows and industry conferences. Those excursions allowed him to fully grasp what Nvidia was showcasing at its GTC conferences and see some of the impressive updates on display at the automotive show. Through this he gained incredible insight into, and conviction in, what have become some of today’s best-performing stocks.

It’s also allowed him to meet some very smart, very talented investors — both here on InvestorPlace and elsewhere. Perhaps more than anything, their lessons, findings and techniques have found a way into his process over the years.

There are a million different ways to make money in the stock market. To find the process that works best for you is long and filled with setbacks. Bret’s hope is that part of his process can become part of yours; and together become better investors.

You can follow Bret on Twitter and on LinkedIn.

Recent Articles

Can Nvidia Stock March Back to $200? 

Can Nvidia stock make its way back to $200 per share? Perhaps, but we need to see NVDA clear some of these headwinds first.

Nasdaq Today: Hard to Keep Track of the Losers

Biotech rallied on a $63 billion deal between AbbVie and Allergan. But other than that, it was a tough day for the Nasdaq today.

5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB

AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.

Is Nio Stock the Next Tesla?

Bulls want to believe that Nio stock is the next Tesla, but the charts show how much it's struggling. What should investors do with NIO now?

Nasdaq Today: Celgene, Ulta, Caesars’ Buyout

Celgene and Bristol-Myers Squibb stocks took a hit, video games rallied and Caesars Entertainment entered into a $17.3 billion merger. Here's the Nasdaq Today report.

5 Top Stock Trades for Tuesday: CELG, BMY, CZR

Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.

If iQiyi Stock Is The Netflix Of China, Why Doesn’t It Perform Like It?  

iQiyi stock has been struggling despite posting strong revenue growth and monstrous user growth. Will IQ stock ever find some love?

Nasdaq Today: Maintaining Altitude Amid Uncertainty

PayPal, Slack, and chip stocks like AMD and Nvidia, Micron and Nio were all big movers in the Nasdaq today. Get the scoop, now.

5 Top Stock Trades for Monday: AAPL, XOM, NVTA

Apple, Nio, Exxon Mobil, Invitae and The Trade Desk are our top stock trades for Monday. See what their charts look like now.

Nasdaq Today: When Will We Get New Highs?

Oracle and Adobe rallied hard on the day, while the Nasdaq floats below prior highs. We need FAANG stocks to step up to the plate now.